Biography

Wei Fu has served as a member of the Board of Directors since June 2018. Mr. Fu was appointed Executive Chairman in September 2025, while previously serving as Chairman from July 2024 to September 2025. Mr. Fu also serves as the Chief Executive Officer of CBC Group (previously known as C-Bridge Capital), a healthcare-focused private equity firm, since its founding in April 2014. From 2011 to 2013, Mr. Fu served as the general manager of the investment department at Far East Horizon International (HKEX: 3360), a financial services organization. Mr. Fu served as a partner and the head of the Beijing office of Themes Investment Management Ltd, a private equity firm specializing in healthcare and environmental businesses, from 2010 to 2011. From 2008 to 2010, Mr. Fu worked as an associate director of the private equity department at Standard Chartered Business Consulting (Beijing) Co., Ltd, where he was responsible for private equity investment in relation to infrastructure projects. Mr. Fu was a business analyst at Macquarie Capital (Singapore) Pte. Limited from 2006 to 2008. Mr. Fu currently serves on the board of directors of Everest Medicines Limited (HKEX: 1952), appointed as the director in July 2017 and re-designated as a non-executive director in October 2025. He also serves on the board of directors of several private companies including Abio-X Holdings Limited and AffaMed Therapeutics Limited. Mr. Fu earned a Bachelor’s in Electrical Engineering and Business Administration from Nanyang Technological University in Singapore.